Physician profile
Michael Burris
NPI 1003029828
$859.79
in general payments reported to CMS, 2019-2025
12 companies · $183 in 2025
The $183 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $22.86 · 2021: $322 · 2022: $101 · 2023: $95.51 · 2024: $136 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $414.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $200.78 | 2021 | |
| Core Surgical Group | $154.11 | 2025 | |
| Smith+Nephew, INC. | $128.42 | 2022-2023 | Healicoil |
| Janssen Pharmaceuticals, INC | $99.99 | 2021 | |
| Linvatec Corporation | $97.07 | 2024 | Biobrace 23mm |
| Bioventus LLC | $50.31 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Si-Bone, INC. | $38.24 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $22.86 | 2020 | |
| Axsome Therapeutics, INC. | $22.36 | 2024 | Sunosi |
| Orthofix Medical, INC. | $17.07 | 2023 | Physio-Stim, Spinal-Stim |
| Vericel Corporation | $16.14 | 2024 | Maci |
| Davol INC. | $12.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Burris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.